The COVID pandemic ushered mRNA vaccines into the spotlight, and the technology has even greater potential. Here’s what to ...

Gronvall reminded the audience there are currently two vaccines that do work to prevent cancer: the hepatitis B vaccine given ...

In this podcast, recorded at the 2024 Immuno-Oncology 360º Summit, Dr Margaret Callahan, University of Connecticut, goes over the history of tumor vaccines in immuno-oncology, particularly the lessons ...

The FDA is reviewing the first mRNA flu vaccine for adults 50 and older. Learn how this technology could lead to faster and ...

A healthcare worker places vials containing doses of the "Comirnaty" Pfizer BioNTech and Moderna vaccines against the coronavirus disease (COVID-19) on a table at a vaccination centre in Ronda, Spain ...

As RNA therapeutics evolve far beyond their vaccine origins, a new generation of scientists and manufacturers is rethinking how to produce these complex medicines safely, efficiently, and at scale.

Researchers are edging closer to something long imagined but never quite within reach: a single vaccine platform that could be adapted to fight many kinds of cancer. Early experiments in animals and ...

There's renewed debate on the future of mRNA vaccines, and Johns Hopkins researchers want to clear up some misconceptions around the shots. The mRNA vaccines gained attention during the height of ...

Since being sworn in as Health and Human Services (HHS) secretary, Robert F. Kennedy Jr has repeatedly tried to undermine public trust in vaccines. His agency recently took steps to slow down the ...

Many people first learned about mRNA vaccines during the coronavirus pandemic, when the companies Pfizer-BioNTech and Moderna released their COVID-19 vaccines. The Pfizer-BioNTech shot was the first ...